C4 Therapeutics

CCCC • NASDAQ • Stock Fundamentals

C4 Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Andrew J. Hirsch, with a market cap of $385.9M.

Market Cap$385.9M

Employees145.0

CEOAndrew J. Hirsch

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about C4 Therapeutics

C4 Therapeutics (CCCC) has a market capitalization of $385.9M and trades on NASDAQ.

C4 Therapeutics has approximately 145 employees.